Awarded

BLINATUMOMAB 38.5 ΜG PÓ CONC SOL SOL INJ FR IV

Name: BLINATUMOMAB 38.5 ΜG PÓ CONC SOL SOL INJ FR IV
Creator: Unidade Local de Saúde de Coimbra, EPE
Published: 2026-11-03
License: https://ted.europa.eu/en/simap/legal-notice

Original language: Portuguese

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Buyer: Unidade Local de Saúde de Coimbra, EPE
Winners: AMGEN - BIO-FARMACÊUTICA, LDA.
Contract value: €165,657
Bids received: 1
Published: 3 Nov 2026
Awarded: 8 Oct 2026
Contract start: 8 Oct 2026
Contract end: 25 Oct 2027estimated
Sector: Medical equipment and pharmaceuticals
Region: Cávado
Source: Original notice on TED (768914-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
BRODALUMAB 210 MG/1.5 ML SOL INJ SER 1.5 ML SC	Unidade Local de Saúde de Coimbra, EPE	LEO Farmacêuticos, Limitada	€36,904	3 Nov 2026
GILTERITINIB 40 MG COMP	Unidade Local de Saúde de Coimbra, EPE	ASTELLAS FARMA, LDA.	€171,182	3 Nov 2026
BRIGATINIB 30 MG COMP	Unidade Local de Saúde de Coimbra, EPE	TAKEDA - FARMACÊUTICOS PORTUGAL, LDA.	€104,714	3 Nov 2026
PONATINIB 45 MG COMP	Unidade Local de Saúde de Coimbra, EPE	CENCORA 3PL PORTUGAL, S.A.	€6,913	3 Nov 2026
DAROLUTAMIDA 300 MG COMP	Unidade Local de Saúde de Coimbra, EPE	Bayer Portugal, Lda.	€702,751	3 Nov 2026
BINIMETINIB 15 MG COMP	Unidade Local de Saúde de Coimbra, EPE	Pierre Fabre Médicament Portugal, Lda.	€459,186	3 Nov 2026